30 April 2020

Registration Updates & Recalls for Pharmaceutical Products & Medical Devices

Reference: CIR-2019-00000334

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Recall all batch’s for pharmaceutical product Dibase 300000, 100000 I.U. ml/IM & oral
• Removal of Registration Suspension Import & Marketing of the product Daroxime 500mg tablet
• Recall medical device Ellipse Implantable Cardioverter defibrillators

 

 Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Recall medical device Ellipse Implantable Cardioverter defibrillators.pdf:

View Document

Removal of Registration Suspension Import _ Marketing of the product Daroxime 500mg tablet.pdf:

View Document

Recall all batchs for pharmaceutical product Dibase 300000 _ 100000 IU ml per IM _ oral.pdf:

View Document